CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified Cells
Open Access
- 31 May 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (5), 448-456
- https://doi.org/10.1006/mthe.2000.0068
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Reversible Expression of CD34 by Murine Hematopoietic Stem CellsBlood, 1999
- Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS DeviceJournal of Hematotherapy, 1999
- Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cellsNature Medicine, 1998
- Impact of a new generation of gene transfer markers on gene therapyGene Therapy, 1998
- Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) GeneHuman Gene Therapy, 1997
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Transduction of Human Hematopoietic Cells and Cell Lines Using a Retroviral Vector Containing a Modified Murine CD4 Reporter GeneHuman Gene Therapy, 1997
- Measuring gene–transfer efficiencyNature Medicine, 1996
- Cell–surface markers for assessing gene transfer into human hematopoietic cellsNature Medicine, 1996
- CD34: structure, biology, and clinical utility [see comments]Blood, 1996